과제정보
연구 과제번호 : Externally Actuatable Nanorobot System for Precise Targeting and Controlled Releasing of Drugs
참고문헌
- Xu L, et al. A reactive oxygen species-responsive prodrug micelle with efficient cellular uptake and excellent bioavailability. J Mater Chem B. 2018; 6:1076-84.
- Shi JJ, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17:20-37.
- Panieri E, Santoro MM. ROS homeostasis and metabolism: a dangerous liason in cancer cells. Cell Death Dis. 2016;7:e2253
- Jiang W, von Roemeling CA, Chen YX, Qie YQ, Liu XJ, Chen JZ, Kim BYS. Designing nanomedicine for immuno-oncology. Nat Biomed Eng. 2017;1 :0029.
- Singh R, et al. Dose-dependent therapeutic distinction between active and passive targeting revealed using transferrin-coated PGMA nanoparticles. Small. 2016;12:351-9.
- Du J, Lane LA, Nie S. Stimuli-responsive nanoparticles for targeting the tumor microenvironment. J Control Release. 2015;219:205-14.
- Rosenblum D, Joshi N, Tao W, Karp JM, Peer D. Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun. 2018;9:1410.
- Xia F, et al. pH-responsive gold nanoclusters-based nanoprobes for lung cancer targeted near-infrared fluorescence imaging and chemophotodynamic therapy. Acta biomaterialia. 2018;68:308-19.
- Hao YW, et al. Tumor acidity-activatable manganese phosphate nanoplatform for amplification of photodynamic cancer therapy and magnetic resonance imaging. Acta Biomater. 2017;62:293-305.
- Shi XX, et al. pH-responsive unimolecular micelles based on amphiphilic star-like copolymers with high drug loading for effective drug delivery and cellular imaging. J Mater Chem B. 2017;5:6847-59.
- Lin WJ, Yao N, Qian L, Zhang XF, Chen Q, Wang JF, Zhang LJ. pH-responsive unimolecular micelle-gold nanoparticles-drug nanohybrid system for cancer theranostics. Acta Biomater. 2017;58:455-65.
- Fang S, et al. Dual-stimuli responsive Nanotheranostics for multimodal imaging guided Trimodal synergistic therapy. Small. 2017;13.
- Chen Q, Feng LZ, Liu JJ, Zhu WW, Dong ZL, Wu YF, Liu Z. Intelligent albumin-MnO2 nanoparticles as pH-/H2O2-responsive dissociable Nanocarriers to modulate tumor hypoxia for effective combination therapy (vol 28, pg 7129, 2016). Adv Mater. 2018;30.
- Feng LL, et al. Controllable generation of free radicals from multifunctional heat-responsive Nanoplatform for targeted Cancer therapy. Chem Mater. 2018;30:526-39.
- Yang GB, et al. Manganese dioxide coated WS2@Fe3O4/sSiO(2) Nanocomposites for pH-responsive MR imaging and oxygen-elevated synergetic therapy. Small. 2018;14.
- Cho MH, Choi ES, Kim S, Goh SH, Choi Y. Redox-responsive manganese dioxide nanoparticles for enhanced MR imaging and radiotherapy of lung Cancer. Front Chem. 2017;5:109.
- Moreira AF, Dias DR, Correia IJ. Stimuli-responsive mesoporous silica nanoparticles for cancer therapy: a review. Micropor Mesopor Mat. 2016; 236:141-57.
- Li JM, Liu F, Shao Q, Min YZ, Costa M, Yeow EKL, Xing BG. Enzymeresponsive cell-penetrating peptide conjugated Mesoporous silica quantum dot Nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells. Adv Healthc Mater. 2014;3:1230-9.
- Hu QY, Katti PS, Gu Z. Enzyme-responsive nanomaterials for controlled drug delivery. Nanoscale. 2014;6:12273-86.
- de la Rica R, Aili D, Stevens MM. Enzyme-responsive nanoparticles for drug release and diagnostics. Adv Drug Deliver Rev. 2012;64:967-78.
- Bailey KM, Wojtkowiak JW, Cornnell HH, Ribeiro MC, Balagurunathan Y, Hashim AI, Gillies RJ. Mechanisms of buffer therapy resistance. Neoplasia. 2014;16:354-364 e351-353.
- Bogurcu N, Seidel S, Garvalov BK, Acker T. Analysis of hypoxia and the hypoxic response in tumor Xenografts. Methods Mol Biol. 2018;1742: 283-300.
- Wilson WR, Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer. 2011;11:393-410.
- Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005;307:58-62.
- Radisky ES, Raeeszadeh-Sarmazdeh M, Radisky DC. Therapeutic potential of matrix metalloproteinase inhibition in breast Cancer. J Cell Biochem. 2017;118:3531-48.
- Kessenbrock K, Plaks V, Werb Z. Matrix Metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141:52-67.
- Jiang T, Olson ES, Nguyen QT, Roy M, Jennings PA, Tsien RY. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. P Natl Acad Sci USA. 2004;101:17867-72.
- Wang L, Huo M, Chen Y, Shi J. Tumor Microenvironment-Enabled Nanotherapy. Adv Healthc Mater. 2017;7:1704490.
- Mo R, Gu Z. Tumor microenvironment and intracellular signal-activated nanomaterials for anticancer drug delivery. Mater Today. 2016;19:274-83.
- John JV, Uthaman S, Augustine R, Chen HY, Park IK, Kim I. pH/redox dual stimuli-responsive sheddable nanodaisies for efficient intracellular tumourtriggered drug delivery. J Mater Chem B. 2017;5:5027-36.
- Johnson RP, et al. Glutathione and endosomal pH-responsive hybrid vesicles fabricated by zwitterionic polymer block poly(L-aspartic acid) as a smart anticancer delivery platform. React Funct Polym. 2017;119:47-56.
- John JV, Uthaman S, Augustine R, Lekshmi KM, Park IK, Kim I. Biomimetic pH/redox dual stimuli-responsive zwitterionic polymer block poly((L)-histidine) micelles for intracellular delivery of doxorubicin into tumor cells. J Polym Sci Pol Chem. 2017;55:2061-70.
- Johnson RP, et al. Poly(PEGA)-b-poly(L-lysine)-b-poly(L-histidine) hybrid vesicles for Tumoral pH-triggered intracellular delivery of doxorubicin hydrochloride. Acs Appl Mater Inter. 2015;7:21770-9.
- Kang EB, Lee JE, Mazrad ZAI, In I, Jeong JH, Park SY. pH-responsible fluorescent carbon nanoparticles for tumor selective theranostics via pHturn on/off fluorescence and photothermal effect in vivo and in vitro. Nanoscale. 2018;10:2512-23.
- Zhang M, et al. Ingenious pH-sensitive dextran/mesoporous silica nanoparticles based drug delivery systems for controlled intracellular drug release. Int J Biol Macromol. 2017;98:691-700.
- Zhu S, Lansakara-P DS, Li X, Cui Z. Lysosomal delivery of a lipophilic gemcitabine prodrug using novel acid-sensitive micelles improved its antitumor activity. Bioconjug Chem. 2012;23:966-80.
- Thambi T, Deepagan VG, Yoo CK, Park JH. Synthesis and physicochemical characterization of amphiphilic block copolymers bearing acid-sensitive orthoester linkage as the drug carrier. Polymer. 2011;52:4753-9.
- Zha Q, Wang X, Cheng X, Fu SX, Yang GQ, Yao WJ, Tang RP. Aciddegradable carboxymethyl chitosan nanogels via an ortho ester linkage mediated improved penetration and growth inhibition of 3-D tumor spheroids in vitro. Mat Sci Eng C-Mater. 2017;78:246-57.
- Belali S, Karimi AR, Hadizadeh M. Cell-specific and pH-sensitive nanostructure hydrogel based on chitosan as a photosensitizer carrier for selective photodynamic therapy. Int J Biol Macromol. 2018;110: 437-48.
- Tao YC, Liu SW, Zhang Y, Chi ZG, Xu JR. A pH-responsive polymer based on dynamic imine bonds as a drug delivery material with pseudo target release behavior. Polym Chem-Uk. 2018;9:878-84.
- Popat A, Liu J, Lu GQ, Qiao SZ. A pH-responsive drug delivery system based on chitosan coated mesoporous silica nanoparticles. J Mater Chem. 2012;22: 11173-8.
- Liao JH, et al. Tumor-targeting and pH-responsive nanoparticles from hyaluronic acid for the enhanced delivery of doxorubicin. Int J Biol Macromol. 2018;113:737-47.
- He H, et al. Selective cancer treatment via photodynamic sensitization of hypoxia-responsive drug delivery. Nanoscale. 2017;10:2856-65.
- Perche F, Biswas S, Wang T, Zhu L, Torchilin VP. Hypoxia- targeted siRNA delivery. Angew Chem Int Edit. 2014;53:3362-6.
- Xie ZQ, et al. Targeting tumor hypoxia with stimulus-responsive nanocarriers in overcoming drug resistance and monitoring anticancer efficacy. Acta Biomater. 2018;71:351-62.
- Yang GB, et al. Smart Nanoreactors for pH-responsive tumor homing, mitochondria-targeting, and enhanced photodynamic-immunotherapy of Cancer. Nano Lett. 2018;18:2475-84.
- Sun L, et al. Cell-permeable, MMP-2 Activatable, nickel ferrite and his-tagged fusion protein self-assembled fluorescent Nanoprobe for tumor magnetictargeting and imaging. Acs Appl Mater Inter. 2017;9:39209-22.
- Ma P, et al. Overcoming multidrug resistance through the GLUT1-mediated and enzyme-triggered mitochondrial targeting conjugate with redoxsensitive paclitaxel release. Acs Appl Mater Inter. 2018;15(10):12351-63.
- Ansari C, et al. Development of novel tumor-targeted Theranostic nanoparticles activated by membrane-type matrix Metalloproteinases for combined Cancer magnetic resonance imaging and therapy. Small. 2014;10:566-75.
- Sharma A, Kim EJ, Shi H, Lee JY, Chung BG, Kim JS. Development of a theranostic prodrug for colon cancer therapy by combining ligand-targeted delivery and enzyme-stimulated activation. Biomaterials. 2018;155:145-51.
- Luo C, et al. Facile Fabrication of Tumor Redox-Sensitive Nanoassemblies of Small-Molecule Oleate Prodrug as Potent Chemotherapeutic Nanomedicine. Small (Weinheim an der Bergstrasse, Germany). 2016;12(46):6353-62. https://doi.org/10.1002/smll.201601597
- Sun C, Li X, Du X, Wang T. Redox-responsive micelles for triggered drug delivery and effective laryngopharyngeal cancer therapy. Int J Biol Macromol. 2018;112:65-73.
- Zhou Y, Wang S, Ying X, Wang Y, Geng P, Deng A, Yu Z. Doxorubicinloaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer. Int J Nanomedicine. 2017;12:6153-68.
- Xia YC, et al. Polycarbonate-based core-crosslinked redox-responsive nanoparticles for targeted delivery of anticancer drug. J Mater Chem B. 2018;6:3348-57.
- Aubry S, et al. Cell-surface thiols affect cell entry of disulfide-conjugated peptides. FASEB J. 2009;23:2956-67.
- Lux CD, Joshi-Barr S, Nguyen T, Mahmoud E, Schopf E, Fomina N, Almutairi A. Biocompatible polymeric nanoparticles degrade and release cargo in response to biologically relevant levels of hydrogen peroxide. J Am Chem Soc. 2012;134:15758-64.
-
Sun C, et al. A ROS-responsive polymeric micelle with a
${\pi}$ -conjugated thioketal moiety for enhanced drug loading and efficient drug delivery. Org Biomol Chem. 2017;15:9176-85. - Dai L, et al. Photosensitizer enhanced disassembly of amphiphilic micelle for ROS-response targeted tumor therapy in vivo. Biomaterials. 2016;104:1-17.
- Yu L, Yang Y, Du F-SS, Li Z-CC. ROS-responsive Chalcogen-containing polycarbonates for photodynamic therapy. Biomacromolecules. 2018;19:2182-93.
- Xiong D, Zhang XF, Peng SY, Gu HW, Zhang LJ. Smart pH-sensitive micelles based on redox degradable polymers as DOX/GNPs carriers for controlled drug release and CT imaging. Colloid Surface B. 2018;163:29-40.
- Chen Q, Feng L, Liu J, Zhu W, Dong Z, Wu Y, Liu Z. Intelligent Albumin-MnO2Nanoparticles as pH-/H2O2-Responsive Dissociable Nanocarriers to Modulate Tumor Hypoxia for Effective Combination Therapy. Advanced materials (Deerfield Beach, Fla). 2018;30:7129-36.
- Jia X, Zhang Y, Zou Y, Wang Y, Niu D, He Q, Huang Z, Zhu W, Tian H, Shi J, Li Y. Dual Intratumoral Redox/Enzyme-Responsive NO-Releasing Nanomedicine for the Specific, High-Efficacy, and Low-Toxic Cancer Therapy. Advanced Materials. 2018;30(30):1704490.
- Feng QS, et al. Self-assembly of gold nanoparticles shows microenvironment-mediated dynamic switching and enhanced brain tumor targeting. Theranostics. 2017;7:1875-89.
- Feng Q, et al. Hypoxia-specific therapeutic agents delivery nanotheranostics: a sequential strategy for ultrasound mediated on-demand tritherapies and imaging of cancer. J Control Release. 2018;275:192-200.
- He H, Zhu RY, Sun W, Cai KM, Chen YB, Yin LC. Selective cancer treatment via photodynamic sensitization of hypoxia-responsive drug delivery. Nanoscale. 2018;10:2856-65.
피인용 문헌
- Integrating nanomedicine into clinical radiotherapy regimens vol.144, pp.None, 2018, https://doi.org/10.1016/j.addr.2019.07.002
- Causes, consequences, and therapy of tumors acidosis vol.38, pp.1, 2018, https://doi.org/10.1007/s10555-019-09792-7
- H2O2-responsive nano-prodrug for podophyllotoxin delivery vol.7, pp.6, 2019, https://doi.org/10.1039/c9bm00344d
- In Situ Synthesis of Amino Acid Functionalized Carbon Dots with Tunable Properties and Their Biological Applications vol.2, pp.8, 2018, https://doi.org/10.1021/acsabm.9b00374
- Nanotechnology and Immunotherapy in Ovarian Cancer: Tracing New Landscapes vol.370, pp.3, 2019, https://doi.org/10.1124/jpet.118.254979
- Hyaluronic Acid-Conjugated with Hyperbranched Chlorin e6 Using Disulfide Linkage and Its Nanophotosensitizer for Enhanced Photodynamic Therapy of Cancer Cells vol.12, pp.19, 2018, https://doi.org/10.3390/ma12193080
- A γ-cyclodextrin-based metal-organic framework embedded with graphene quantum dots and modified with PEGMA via SI-ATRP for anticancer drug delivery and therapy vol.11, pp.43, 2018, https://doi.org/10.1039/c9nr06195a
- Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers vol.7, pp.48, 2018, https://doi.org/10.1039/c9tb01842e
- Tumor microenvironment-responsive contrast agents for specific cancer imaging: a narrative review vol.3, pp.4, 2018, https://doi.org/10.1097/jbr.0000000000000075
- Synthetic immunity by remote control vol.10, pp.8, 2018, https://doi.org/10.7150/thno.41305
- Nano-Therapies for Glioblastoma Treatment vol.12, pp.1, 2018, https://doi.org/10.3390/cancers12010242
- Enhanced cytotoxicity of a redox-sensitive hyaluronic acid-based nanomedicine toward different oncocytes via various internalization mechanisms vol.27, pp.1, 2018, https://doi.org/10.1080/10717544.2019.1709919
- Extracellular Acidosis Promotes Metastatic Potency via Decrease of the BMAL1 Circadian Clock Gene in Breast Cancer vol.9, pp.4, 2018, https://doi.org/10.3390/cells9040989
- Factors Influencing the Delivery Efficiency of Cancer Nanomedicines vol.21, pp.4, 2018, https://doi.org/10.1208/s12249-020-01691-3
- Overview of tumor environment responsive nano-drug delivery systems in tumor immunotherapy vol.512, pp.None, 2018, https://doi.org/10.1088/1755-1315/512/1/012096
- Enhanced nanoparticle accumulation by tumor-acidity-activatable release of sildenafil to induce vasodilation vol.8, pp.11, 2018, https://doi.org/10.1039/d0bm00466a
- Affinity-Driven Design of Cargo-Switching Nanoparticles to Leverage a Cholesterol-Rich Microenvironment for Atherosclerosis Therapy vol.14, pp.6, 2018, https://doi.org/10.1021/acsnano.9b08216
- Evaluating the benefits of renin-angiotensin system inhibitors as cancer treatments vol.211, pp.None, 2018, https://doi.org/10.1016/j.pharmthera.2020.107527
- Smart stimuli-responsive biopolymeric nanomedicines for targeted therapy of solid tumors vol.15, pp.22, 2018, https://doi.org/10.2217/nnm-2020-0146
- Development of pH/Glutathione-Responsive Theranostic Agents Activated by Glutathione S-Transferase π for Human Colon Cancer vol.63, pp.17, 2018, https://doi.org/10.1021/acs.jmedchem.0c00354
- Electrospray-based synthesis of fluorescent poly(D,L-lactide-co-glycolide) nanoparticles for the efficient delivery of an anticancer drug and self-monitoring its effect i vol.1, pp.8, 2018, https://doi.org/10.1039/d0ma00646g
- An Overview of Bioactive Natural Products-Based Nano-Drug Delivery Systems in Antitumor Chemotherapy vol.271, pp.None, 2018, https://doi.org/10.1051/e3sconf/202127103042
- TME-Responsive Multistage Nanoplatform for siRNA Delivery and Effective Cancer Therapy vol.16, pp.None, 2018, https://doi.org/10.2147/ijn.s322901
- Drug Delivery of Natural Products Through Nanocarriers for Effective Breast Cancer Therapy: A Comprehensive Review of Literature vol.16, pp.None, 2021, https://doi.org/10.2147/ijn.s328135
- Underlying mechanisms and drug intervention strategies for the tumour microenvironment vol.40, pp.1, 2021, https://doi.org/10.1186/s13046-021-01893-y
- Tumor-Acidity Responsive Polymeric Nanoparticles for Targeting Delivery of Angiogenesis Inhibitor for Enhanced Antitumor Efficacy With Decreased Toxicity vol.9, pp.None, 2018, https://doi.org/10.3389/fbioe.2021.664051
- Noyes-Whitney Dissolution Model-Based pH-Sensitive Slow Release of Paclitaxel (Taxol) from Human Hair-Derived Keratin Microparticle Carriers vol.2021, pp.None, 2018, https://doi.org/10.1155/2021/6657482
- Nanotherapeutics and Nanotheragnostics for Cancers: Properties, Pharmacokinetics, Biopharmaceutics, and Biosafety vol.27, pp.None, 2021, https://doi.org/10.2174/1381612827666210804102645
- Reactive Oxygen Species‐Regulating Strategies Based on Nanomaterials for Disease Treatment vol.8, pp.3, 2018, https://doi.org/10.1002/advs.202002797
- Surface engineered amphiphilic carbon dots: solvatochromic behavior and applicability as a molecular probe vol.9, pp.5, 2021, https://doi.org/10.1039/d0tb02007a
- Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery vol.18, pp.2, 2018, https://doi.org/10.1080/17425247.2021.1828339
- Emerging Strategies in Anticancer Combination Therapy Employing Silica‐Based Nanosystems vol.16, pp.3, 2018, https://doi.org/10.1002/biot.201900438
- Nanovectorization of Prostate Cancer Treatment Strategies: A New Approach to Improved Outcomes vol.13, pp.5, 2018, https://doi.org/10.3390/pharmaceutics13050591
- Intelligent Nanoparticle-Based Dressings for Bacterial Wound Infections vol.4, pp.5, 2018, https://doi.org/10.1021/acsabm.0c01168
- Role of intravital imaging in nanomedicine-assisted anti-cancer therapy vol.69, pp.None, 2018, https://doi.org/10.1016/j.copbio.2020.12.024
- Evaluation of the Anticancer Activity of Phytomolecules Conjugated Gold Nanoparticles Synthesized by Aqueous Extracts of Zingiber officinale (Ginger) and Nigella sativa L. Seeds (Black Cumin) vol.14, pp.12, 2018, https://doi.org/10.3390/ma14123368
- Anisamide-modified dual-responsive drug delivery system with MRI capacity for cancer targeting therapy vol.340, pp.None, 2021, https://doi.org/10.1016/j.molliq.2021.116889